Thomas M. Stepien, who serves as both Chief Executive Officer and a director at Amprius Technologies, Inc. (NASDAQ:AMPX), executed a transaction disposing of company shares valued at $41,940 on June 4, 2026, according to a recent filing with the Securities and Exchange Commission. The sale was executed at a price of $20.97 per share, resulting in the disposal of 2,000 shares of common stock. This activity occurs as the stock trades at $19.69, a level positioned near its 52-week high of $24.23, following a substantial 757% gain over the past year.
Following the completion of this transaction, Mr. Stepien's direct ownership in the company stands at 625,625 shares. This total includes 615,625 restricted stock units, which represent a contingent right to receive common stock, subject to vesting schedules. The filing also documented several additional transfers of common stock on the same date for which no price was paid. Specifically, Mr. Stepien made bona fide gifts of 30,384 shares. Additionally, he transferred 36,914 shares to the Rogers Stepien Family Revocable Trust. These shares were subsequently acquired by the trust, for which Mr. Stepien and his spouse serve as co-trustees. Following these transactions, Mr. Stepien directly holds 625,625 shares, which includes the restricted stock units, and indirectly holds 36,914 shares through the Rogers Stepien Family Revocable Trust.
According to InvestingPro analysis, which indicates the stock is currently overvalued, the company holds more cash than debt on its balance sheet, though it remains unprofitable. Investors can access 15 additional ProTips and comprehensive analysis through the platform’s detailed Pro Research Report.
In other recent news, Amprius Technologies reported its Q1 2026 earnings, showing a net loss of $5 million or -$0.04 per share, which was below the forecasted -$0.0278 per share. However, the company exceeded revenue expectations with $28.5 million, surpassing the predicted $25.32 million. This earnings report has been a focal point for investors, reflecting mixed results with a revenue beat but an earnings miss. Meanwhile, Amprius Technologies has entered a collaboration with Matternet to supply silicon anode lithium-ion batteries for Matternet’s M2 delivery drones. This partnership aims to expand with the development of battery solutions for Matternet’s next-generation platform, planned for early 2027. Additionally, short seller Manatee Research released a report alleging exaggerated orders and disclosure irregularities at Amprius Technologies. The investigation by Manatee Research involved interviews and legal filings, raising concerns about the company’s operations. These developments are shaping the current landscape for Amprius Technologies, as investors assess the implications of both the earnings results and the short seller’s allegations.